A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus InfectionSamuel A. Bozzette, Judith Feinberg, Lucinda Phillips et al.|New England Journal of Medicine|1995Cited by 339
Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseasesBinhua Zou, Xiaojuan Li, Qinghe Liang et al.|Pharmacological Research|2025Cited by 1